Capital optimization through an innovative CVA hedge

Abstract

One of the lessons of the financial crisis as of late was the inherent credit risk attached to the value of derivatives. Since not all derivatives can be cleared by central counterparties, a significant amount of OTC derivatives will be subject to increased regulatory capital charges. These charges cover both current and future unexpected losses; the capital costs for derivatives transactions can become substantial if not prohibitive. At the same time, capital optimization through CDS hedging of counterparty risks will result in a hedge position beyond the economic risk (“overhedging”) required to meet Basel II/III rules. In addition, IFRS accounting rules again differ from Basel, creating a mismatch when hedging CVA. Even worse, CVA hedging using CDS may introduce significant profit and loss volatility while satisfying the conditions for capital relief. An innovative approach to hedging CVA aims to solve these issues.